PPT-Supplemental Figure 1A: Association between 19

DMSs and dietary intake and lifestyle factors at exam 5 for all participants n1880 log10 P value 60 50 40 30 20 10 132 NutrientsBioactive 129 Food group1 FFD 29 Food group2 FG5Serv. Figure . S1. . . (A) . Schematic shows the three KREN1, KREN2, and KREN3 ~20S editosomes, and their protein interactions identified by yeast two-hybrid and co-expression studies (dashed lines) (Schnaufer et al. 2003; Schnaufer et al. 2010; Mehta et al. 2015). (B-D) Networks show detailed editosome architecture revealed by cross-linking and mass spectrometry (CXMS) (McDermott et al. 2016). Network edge widths are proportional to the number of interlinks observed between two proteins. All previously described interactions between editosome proteins were found in our cross-linking data. . 2012). 345,641 diverse . protein . families. Multiple. sequences. 2. 47. ,. 437. with . at least . 3. homologous. . sequences. Full length. proteins. 224. ,4. 09. . where majority of sequences have . Supplemental Figure 1 Supplemental Figure 2 Supplemental Figure 3 Supplemental Figure 4 Supplemental Table 1 Supplemental Figure 5 CD44. GM130. CD40. MSCs. EVs. B. C. Supplemental Figure 1. Supplemental Figure 2. Supplemental Figure 3 . Supplemental Figure 4. A. B. A. B. C. Supplemental Figure 5. D. SSC. CD206. CD206. 25.7%. 14%. fpkm. ). PD-L1 (. fpkm. ). CD8 (. fpkm. ). Iba1 (. fpkm. ). p. < 0.001. p. < 0.001. p. < 0.001. p. < 0.001. GM-CSF. GM-CSF. GM-CSF. GM-CSF. Supplemental Figure 1. Gene expression analysis in breast cancer cases from TCGA database. Gene expression levels of CD8, Iba1, PD-L1, and PD-L2 in breast cancer were compared between the cases with and without GM-CSF expression. The Mann-Whitney . 1. 5. 10. 30. 50. 100. SP600125. 0,1. 1. 2. 5. 10. 20. ER-27319. 1. 5. 10. 30. 50. 100. Inhibitors concentration (µM). A. B. Supplemental Figure 1: B cell survival (A) . B cells were pre-treated with kinase inhibitors (GF109203 (PKC. With first H2 blockers or PPI prescriptions between October, 2006 and September, 2008. First acid suppression therapy prescription was PPI . First acid suppression therapy prescription was H2 Blockers . GSE47460_GPL14550 . GSE47460_GPL6480 . Supplemental Figure 2. Megakaryocyte score. Platelet score. FVC. DLCO. A. B. Megakaryocyte score. Platelet score. FVC. DLCO. r = -0.09331, p = 0.5237. r = 0.07781, p = 0.6721. suboptimally. positioned. There was a normal . cardiothymic. silhouette. The lungs were clear. Air in scattered loops of . nondilated. small and large bowel, within all four quadrants of the abdomen.. Viral infection. Inflammation response. -log10(. p. -value) -log10(. Scale bar: 10nm. 9.5nm. 14.7nm. Average diameter:. A. B. Supplemental figure 2. ELISA using FT and GnH-FT as antigens. A. B. * P <0.05, ** P<0.01, *** P<0.001, and **** P<0.00001. **. *. *. B. Supplemental Figure 2. Tissue. Adrenal gland . Appendix. Appendix . Bone marrow . Breast . Breast cancer. Bronchus Respiratory . Cartilage. Cerebellum . Cerebellum . Cerebellum . Cerebral cortex. Cerebral cortex. children . aged 2–5 years . in Medicaid receiving . clinical care for . attention-deficit/hyperactivity disorder (ADHD): United States, 2011. 0.45-1.40%. 1.41-1.70%. 1.71-2.05%. 2.06-3.38%. SUPPLEMENTAL FIGURE 5. . Top layer. Bottom layer. PDMS rod. +. cells. Nuclei. F-actin. Supplemental Figure 1: Lung Endothelial MPS. A.. B.. Supplemental Figure 1: A) Schematic of lung endothelial MPS. B) Imaging demonstrating coverage with endothelial cells prior to incubation of plasma in the lumens..